Blog

<p>As obesity rates continue to rise worldwide, the medical community is increasingly focusing on finding effective, minimally invasive solutions for weight management. Traditional surgical approaches, while effective, are not suitable for everyone due to the risks, recovery times, and certain health requirements. To bridge this gap, Endoscopic Sleeve Gastroplasty (ESG) has emerged as a promising option for those looking for less invasive weight-loss procedures.</p><p>Recently, the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) endorsed ESG as an effective method for managing obesity, especially for patients who cannot or prefer not to undergo traditional surgery. This endorsement follows a comprehensive review of ESG, reflecting its rising acceptance as a valuable addition to obesity care. Let’s dive into what ESG is, why it’s significant, and how the IFSO’s review supports its role in obesity treatment.</p><h3>What is Endoscopic Sleeve Gastroplasty (ESG)?</h3><p>ESG is a minimally invasive, endoscopic procedure designed to reduce the stomach’s volume, limiting food intake and helping individuals lose weight. Unlike traditional bariatric surgery, ESG does not require any cuts or large incisions. Instead, the procedure is performed using an endoscope—a flexible tube equipped with a camera and suturing device—that enters the stomach through the mouth.</p><p>Once inside the stomach, the surgeon uses specialized tools to create a series of sutures along the stomach wall, reducing its overall size and forming a sleeve-like structure. This reshaping of the stomach reduces the amount it can hold, helping patients feel full after consuming smaller portions of food. Since ESG preserves the natural anatomy of the digestive system, it also reduces the risks associated with more invasive surgeries.</p><figure id="figure-0ma8sd7kcm30gp8tn"><img id="0ma8sd7kcm30gp8tn" src="https://media.gettyimages.com/id/935049564/photo/microphone-in-front-businesspeople-blurred-in-conference-meeting-room.jpg?b=1&amp;s=2048x2048&amp;w=0&amp;k=20&amp;c=v37FG23D18aLjXAevJsDFvlg6l5WX8R2rPhQHB0Ms7g=" alt="Microphone in front businesspeople blurred in conference meeting room" title="Microphone in front businesspeople blurred in conference meeting room" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionx="undefined" data-positiony="undefined" data-fullwidth="false" data-mce-src="https://media.gettyimages.com/id/935049564/photo/microphone-in-front-businesspeople-blurred-in-conference-meeting-room.jpg?b=1&amp;s=2048x2048&amp;w=0&amp;k=20&amp;c=v37FG23D18aLjXAevJsDFvlg6l5WX8R2rPhQHB0Ms7g=" data-mce-style="aspect-ratio: 16/9; object-position: center center;"></figure><h3>The IFSO Review and Endorsement of ESG</h3><p>The recent endorsement of ESG by IFSO is based on a systematic review conducted by the IFSO Bariatric Endoscopy Committee. This review collected and analyzed data from various studies on ESG, with the aim of evaluating its safety, effectiveness, and role within obesity care. The review included findings from numerous case studies, cohort studies, and even a randomized controlled trial, encompassing a total of over 15,000 patients.</p><p>The review’s findings provided evidence supporting ESG as a valuable option for weight loss, particularly for individuals with obesity who either cannot undergo or choose not to have more invasive procedures. Here are some of the key findings and conclusions from this IFSO-backed review:</p><p><strong>1. Significant Weight Loss Outcomes: </strong>The review found that ESG led to meaningful and sustained weight loss across different study groups. Patients generally experienced a significant percentage of excess weight loss (EWL) and total body weight loss (TBWL) over periods extending up to five years. For example, average TBWL values remained between 14-18% over 24 to 36 months, indicating durable results.</p><p><strong>2. Safety Profile:</strong> The review demonstrated that ESG has a favorable safety profile, with a serious adverse event rate of only 1.25%. This low rate of complications underscores ESG’s position as a safer alternative to more invasive weight-loss surgeries, especially for patients who might have higher surgical risks.</p><p><strong>3. Quality of Evidence: </strong>Although most of the studies included in the review were observational, limiting the level of evidence, the findings from a randomized controlled trial (RCT) included in the review offered more robust support for ESG’s efficacy and safety. The RCT reinforced ESG’s status as a reliable option for weight management, providing a higher level of scientific evidence to back the positive outcomes observed in other study types.</p><figure id="figure-7bljick2r5m30gr7xp"><img id="7bljick2r5m30gr7xp" src="https://media.gettyimages.com/id/1369119099/photo/doctor-or-nurse-with-clipboard-working-at-hospital.jpg?b=1&amp;s=2048x2048&amp;w=0&amp;k=20&amp;c=fQrzPfoLpLXkzuusVwSj0QDY9umFHJv-SLp_wvNTJYk=" alt="doctor or nurse with clipboard working at hospital" title="doctor or nurse with clipboard working at hospital" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionx="undefined" data-positiony="undefined" data-fullwidth="false" data-mce-src="https://media.gettyimages.com/id/1369119099/photo/doctor-or-nurse-with-clipboard-working-at-hospital.jpg?b=1&amp;s=2048x2048&amp;w=0&amp;k=20&amp;c=fQrzPfoLpLXkzuusVwSj0QDY9umFHJv-SLp_wvNTJYk=" data-mce-style="aspect-ratio: 16/9; object-position: center center;"></figure><h3>Why ESG is an Important Development in Obesity Treatment</h3><p>The IFSO’s endorsement of ESG signals a shift toward accepting less invasive methods as part of mainstream obesity treatment. Here’s why ESG’s position in obesity care is so important:</p><p><strong>• Alternative for High-Risk Patients:</strong> Many patients with obesity have health conditions that make them poor candidates for surgery. ESG provides a viable alternative for these patients, offering significant weight loss without the high risks associated with surgical interventions.</p><p><strong>• Options for Those with Lower BMI:</strong> Some individuals with a BMI below the threshold for traditional surgery still struggle with obesity-related health conditions, but they may not qualify for traditional metabolic and bariatric surgery (MBS). ESG fills this gap, providing an option for patients with class I and II obesity who may still benefit from medical intervention.</p><p><strong>• Reduced Healthcare Burden: </strong>Because ESG can often be performed as an outpatient procedure, it reduces the time patients need to spend in healthcare facilities, lowers the risk of complications, and generally has a shorter recovery period compared to surgery. This can help reduce healthcare costs and increase accessibility for patients who need treatment.</p><h3>Detailed ESG Outcomes from the IFSO Review</h3><p>The IFSO review looked at weight loss outcomes and complication rates for ESG over time. Here are some of the specific results from the review:</p><p><strong>1. Weight Loss:</strong></p><p>• 6 Months: Patients typically lost an average of 15.66% of their total body weight.</p><p>• 12 Months: At the one-year mark, average weight loss increased to approximately 17.56%.</p><p>• 18-24 Months: Patients continued to lose weight over time, with results peaking around 18 months at nearly 16.25%.</p><p>• Long-Term Results: Even at 36 to 60 months, weight loss remained stable, with mean weight loss percentages staying between 14-15%.</p><p><strong>2. Safety and Complications:</strong></p><p>• The review showed that serious complications were uncommon, with a rate of only 1.25%.</p><p>• Mild side effects, such as nausea or abdominal discomfort, were more common but generally resolved quickly.</p><p><strong>3. Quality of Evidence:</strong></p><p>• While observational studies were the primary source of data, a single RCT in the review provided a more moderate level of evidence for ESG’s safety and effectiveness. The RCT’s findings aligned with those of other studies, reinforcing the reliability of ESG as a weight-loss tool.</p><figure id="figure-d07p6xv346tm30gs9li"><img id="d07p6xv346tm30gs9li" src="https://media.gettyimages.com/id/1740765674/photo/young-woman-taking-measurements-of-her-body-in-front-of-the-mirror-in-her-bedroom.jpg?b=1&s=2048x2048&w=0&k=20&c=tvRbGSgMvnv6VjSS-4d4oZ8ifngCDhNcu0xesogKz5k=" alt="Young woman taking measurements of her body in front of the mirror in her bedroom" title="Young woman taking measurements of her body in front of the mirror in her bedroom" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionX="undefined" data-positionY="undefined" data-fullWidth="false"/></figure><h3>How ESG Compares to Other Weight-Loss Procedures</h3><p>Compared to traditional bariatric surgeries like the gastric bypass or sleeve gastrectomy, ESG offers several distinct advantages:</p><p><strong>• Lower Risk: </strong>ESG has a much lower rate of complications than many traditional surgeries, as it doesn’t involve cutting or stapling parts of the stomach or intestines.</p><p><strong>• Quicker Recovery: </strong>Most patients can return to daily activities within a few days after ESG, whereas recovery from surgical options can take several weeks.</p><p><strong>• Reversibility:</strong> While not commonly reversed, ESG is theoretically reversible by removing the stitches, which is not an option with more permanent procedures like sleeve gastrectomy.</p><p>However, ESG may also have limitations in comparison to traditional surgeries:</p><p>• Less Drastic Weight Loss: While ESG is effective, the amount of weight loss may be slightly less than with traditional surgeries, especially for those with higher BMI levels.</p><h3>The Future of ESG in Obesity Management</h3><p>The IFSO endorsement of ESG is a pivotal development in the field of obesity treatment, as it highlights the potential for ESG to become a standard, widely accepted option within the broader spectrum of obesity care. As more studies are conducted, and additional RCTs build upon the existing data, the medical community will gain an even clearer picture of ESG’s long-term benefits and limitations.</p><p>The IFSO’s endorsement encourages healthcare providers to consider ESG not as an alternative to surgery but as a complementary option. It opens up the possibility of using ESG as part of a multidisciplinary obesity treatment plan, giving doctors more tools to help patients achieve sustainable weight loss.</p><h3>Key Takeaways for Patients Considering ESG</h3><p>If you’re considering ESG as a weight-loss option, here are some essential points to discuss with your healthcare provider:</p><p><strong>1. Eligibility: </strong>ESG is best suited for patients with a BMI between 30 and 40 who haven’t found success with diet and exercise alone.</p><p><strong>2. Expected Outcomes:</strong> ESG offers significant weight loss, but results vary. Your doctor can help you set realistic goals based on your health profile.</p><p><strong>3. Risks and Recovery: </strong>While ESG has a favorable safety profile, mild side effects are possible. Be sure to follow all post-procedure care instructions to minimize risks.</p><p><strong>4. Commitment to Lifestyle Changes: </strong>Like all weight-loss procedures, ESG requires a commitment to healthy eating, exercise, and regular medical follow-up for the best long-term results.</p><h3>Conclusion</h3><p>The IFSO’s endorsement of Endoscopic Sleeve Gastroplasty marks an important step forward in making effective, minimally invasive obesity treatments more accessible. ESG fills a critical gap for patients who cannot or prefer not to undergo traditional surgery, offering a safe and effective way to achieve lasting weight loss.</p><p>As the global health community faces rising rates of obesity, tools like ESG provide new hope. Backed by comprehensive evidence and the support of an influential organization like the IFSO, ESG is well on its way to becoming a cornerstone of obesity management.&nbsp;</p><p><strong>Source:</strong><a href="https://pubmed.ncbi.nlm.nih.gov/39482444/#:~:text=Conclusions%3A%20The%20IFSO%20Bariatric%20Endoscopy,and%20valuable%20treatment%20for%20obesity." data-mce-href="https://pubmed.ncbi.nlm.nih.gov/39482444/#:~:text=Conclusions%3A%20The%20IFSO%20Bariatric%20Endoscopy,and%20valuable%20treatment%20for%20obesity.">IFSO Position Statement</a></p>

Big News! IFSO Endorsed ESG!

Endoscopy at the hospital. Doctor holding endoscope before gastroscopy. Medical examination

<h2>Endoscopic Gastric Sleeve Gastroplasty: A More Cost-Effective and Sustainable Weight Loss Solution Compared to Semaglutide</h2><p>In the ever-evolving landscape of weight loss treatments, a recent study published in JAMA Network Open highlights the cost-effectiveness and efficacy of Endoscopic Sleeve Gastroplasty (ESG) over a five-year period when compared to semaglutide, the active ingredient in popular weight loss drugs like Ozempic and Wegovy. This study underscores the potential of ESG as a more sustainable and affordable option for long-term weight management.</p><h3>What is Endoscopic Sleeve Gastroplasty (ESG)?</h3><p>Endoscopic Sleeve Gastroplasty (ESG) is a nonsurgical weight loss procedure that involves reducing the size of the stomach using a specialized suturing device. Unlike traditional gastric sleeve surgery, which involves surgically removing a large portion of the stomach, ESG uses an endoscopic approach. The procedure is performed by inserting the suturing device through the throat into the stomach, where it folds and sutures the stomach lining, thereby reducing its volume.</p><h3>The Study: Methodology and Key Findings</h3><p>The study conducted between September 1, 2022, and May 31, 2023, utilized a Markov cohort model to simulate the experiences of a hypothetical group of patients over a set period. The participants were adults within the U.S. healthcare system, all having a body mass index (BMI) ranging from 35 to 39.9, which classifies them within the obesity range.</p><p>Initially, over a one-year period, ESG was found to be less cost-effective compared to semaglutide. However, the dynamics shifted significantly when the researchers extended the observation period to five years.&nbsp;</p><figure id="figure-t66szbuasklwtudnyv" class=""><img id="t66szbuasklwtudnyv" src="https://cdn.durable.co/shutterstock/17agWRVGDeZmzaafDs8OJjTVCRmH16ElT8igZD2HcotDMDZdQhTdHcjikSayBOAJ.jpeg" alt="clinic, profession, people, health care and medicine concept - happy group of medics or doctors at hospital corridor" title="clinic, profession, people, health care and medicine concept - happy group of medics or doctors at hospital corridor" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionx="undefined" data-positiony="undefined" data-fullwidth="false" data-mce-src="https://cdn.durable.co/shutterstock/17agWRVGDeZmzaafDs8OJjTVCRmH16ElT8igZD2HcotDMDZdQhTdHcjikSayBOAJ.jpeg" data-mce-style="aspect-ratio: 16/9; object-position: center center;"></figure><h3>Cost Comparison Over Five Years</h3><p>The projections indicated that "the semaglutide strategy" would cost approximately $33,583 more than the ESG strategy over five years. A crucial factor contributing to this cost difference is the likelihood of discontinuation among semaglutide users. The study estimated that about 20% of individuals on semaglutide would stop using the drug due to intolerance or other reasons, leading to probable weight regain.</p><p>Conversely, ESG demonstrated a more enduring solution with greater weight loss and cost savings. The researchers concluded that for semaglutide to be a cost-competitive alternative, its annual cost would need to be drastically reduced from $13,618 to $3,591.</p><h3>Expert Opinions on ESG vs. Semaglutide</h3><p>Marina Kurian, MD, president of the American Society for Metabolic and Bariatric Surgery, highlighted the economic and practical advantages of ESG. According to Dr. Kurian, medications like semaglutide, while initially effective, are expensive and often lead to significant weight regain upon discontinuation. In contrast, patients undergoing surgical weight loss procedures, such as ESG, tend to maintain their weight loss more effectively over the long term, even though some weight regain can occur.</p><p>Dr. Kurian pointed out that weight loss surgeries typically achieve cost recoupment or become cost-neutral over two to three years, reinforcing the financial viability of ESG as a weight loss strategy.</p><h3>The Role of Semaglutide in Weight Loss</h3><p>Originally developed to treat type 2 diabetes, semaglutide gained popularity for its weight loss benefits. The drug functions by stimulating insulin release in response to high blood sugar levels, particularly after meals, and by reducing the amount of sugar produced by the liver. Administered as a weekly injection, semaglutide has proven effective in promoting weight loss.</p><p>However, the long-term economic sustainability of semaglutide is questionable, especially when compared to the more cost-effective ESG. The study suggests that despite its initial success in aiding weight loss, semaglutide may not be a financially viable option over an extended period.</p><figure id="figure-4i7ovaircblwtuemf4" class="selected"><img id="4i7ovaircblwtuemf4" src="https://cdn.durable.co/shutterstock/36TM35VpIDez7yVjXkr12B0WyVaMiNPcapMkAs48zJazgiuIZPUHLcwOdwSqyzTx.jpeg" alt="Healthy fit and sportive couple running in nature at summer day" title="Healthy fit and sportive couple running in nature at summer day" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionx="undefined" data-positiony="undefined" data-fullwidth="false" data-mce-src="https://cdn.durable.co/shutterstock/36TM35VpIDez7yVjXkr12B0WyVaMiNPcapMkAs48zJazgiuIZPUHLcwOdwSqyzTx.jpeg" data-mce-style="aspect-ratio: 16/9; object-position: center center;"></figure><h3>The Importance of Lifestyle Changes</h3><p>Both ESG and semaglutide require a commitment to lifestyle modifications to achieve and maintain weight loss. Medical professionals emphasize the necessity of dietary changes, regular exercise, and other lifestyle adjustments to ensure the success of either treatment. These components are essential in sustaining weight loss and improving overall health outcomes.</p><h3>Conclusion</h3><p>The study published in JAMA Network Open presents compelling evidence that Endoscopic Sleeve Gastroplasty (ESG) is a more cost-effective and sustainable weight loss solution over a five-year period compared to semaglutide. While semaglutide can facilitate initial weight loss, its high cost and the potential for weight regain upon discontinuation make it less economically viable in the long run.</p><p>ESG, with its nonsurgical approach and significant long-term cost savings, offers a promising alternative for individuals seeking effective weight management solutions. By combining ESG with necessary lifestyle changes, patients can achieve and maintain significant weight loss, enhancing their overall health and quality of life.</p><p>For those considering weight loss treatments, it's essential to weigh the costs and benefits of each option. As this study illustrates, ESG may provide a more practical and financially sustainable path to achieving long-term weight loss goals.</p><p>---</p><p>This post aims to provide a detailed comparison of ESG and semaglutide, emphasizing the long-term benefits and cost-effectiveness of ESG for weight loss. It is crucial for individuals to consult with healthcare professionals to determine the most appropriate treatment based on their specific health needs and financial considerations.</p>

ESG is a Cost Effective and Sustainable Solution!

<p>Endoscopic gastroplasty has emerged as a promising minimally invasive procedure for weight loss. Recent studies have highlighted its effectiveness, safety, and potential as an alternative to traditional bariatric surgeries. In this blog post, we will delve into the latest research on endoscopic gastroplasty, exploring its mechanisms, benefits, outcomes, and future prospects.</p><h3>Introduction to Endoscopic Gastroplasty</h3><p>Endoscopic gastroplasty, specifically Endoscopic Sleeve Gastroplasty (ESG), is a non-surgical weight loss procedure that uses an endoscope to reduce the size of the stomach. This technique involves the placement of sutures in the stomach, which creates a sleeve-like effect, limiting food intake and promoting weight loss. Unlike traditional bariatric surgeries, ESG does not require incisions, making it less invasive and reducing recovery time.</p><h3>Mechanisms of Endoscopic Gastroplasty</h3><p>The primary mechanism of ESG involves the endoscopic placement of sutures to create a smaller gastric pouch. This is achieved using a specialized device inserted through the mouth, which allows the gastroenterologist to access the stomach without making external incisions. The sutures are placed in a specific pattern to reduce the stomach’s volume, mimicking the effect of a surgical sleeve gastrectomy. This procedure not only restricts the amount of food the stomach can hold but also slows down the digestive process, leading to early satiety and reduced calorie intake.</p><h3>Recent Studies on Endoscopic Gastroplasty</h3><p>Several recent studies have provided valuable insights into the effectiveness and safety of ESG. These studies have involved a variety of populations and methodologies, contributing to a comprehensive understanding of the procedure.</p><p><strong>1. Effectiveness in Weight Loss:</strong> A study published in The Lancet Gastroenterology &amp; Hepatology in 2023 examined the outcomes of ESG in a large cohort of patients. The study reported an average excess weight loss of 18-20% at one year post-procedure. This is significant compared to traditional weight loss methods, positioning ESG as an effective intervention for obesity.</p><p><strong>&nbsp;2. Safety Profile:</strong> Research has consistently shown that ESG has a favorable safety profile. A meta-analysis published in Gastrointestinal Endoscopy in 2022 reviewed data from multiple studies and found a low incidence of adverse events. The most common complications were mild and included nausea, abdominal pain, and temporary dysphagia. Severe complications were rare, reinforcing the procedure’s safety.</p><p><strong>3. Long-term Outcomes: </strong>Long-term studies are crucial to understanding the sustainability of weight loss and the overall health benefits of ESG. A study published in Obesity Surgery in 2023 followed patients for three years and found that most maintained significant weight loss, with improvements in comorbidities such as diabetes, hypertension, and sleep apnea. This suggests that ESG not only promotes weight loss but also contributes to the management of obesity-related conditions.</p><figure id="figure-eomxxoyiiilwextq8j" class=""><img id="eomxxoyiiilwextq8j" src="https://cdn.durable.co/shutterstock/17agWRVGDeZmzaafDs8OJjTVCRmH16ElT8igZD2HcotDMDZdQhTdHcjikSayBOAJ.jpeg" alt="clinic, profession, people, health care and medicine concept - happy group of medics or doctors at hospital corridor" title="clinic, profession, people, health care and medicine concept - happy group of medics or doctors at hospital corridor" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionx="undefined" data-positiony="undefined" data-fullwidth="false" data-mce-src="https://cdn.durable.co/shutterstock/17agWRVGDeZmzaafDs8OJjTVCRmH16ElT8igZD2HcotDMDZdQhTdHcjikSayBOAJ.jpeg" data-mce-style="aspect-ratio: 16/9; object-position: center center;"></figure><h3>Comparative Studies: ESG vs. Traditional Bariatric Surgery</h3><p>Comparing ESG to traditional bariatric surgeries such as laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) is essential for evaluating its place in weight management strategies.</p><p><strong>&nbsp;1. Weight Loss Comparison:</strong> Studies have shown that while ESG results in less weight loss compared to LSG and RYGB, it still offers substantial benefits. For instance, a comparative study in Surgical Endoscopy in 2022 reported that patients undergoing ESG experienced an average of 20-25% total body weight loss at one year, whereas LSG patients lost around 30-35%. However, the reduced invasiveness and quicker recovery time make ESG an attractive option for many patients.</p><p><strong>&nbsp;2. Recovery and Complications:</strong> One of the significant advantages of ESG is the shorter recovery period. Patients typically return to normal activities within a few days, compared to several weeks for traditional surgeries. Additionally, the risk of complications is lower with ESG. While traditional surgeries carry risks such as leaks, infections, and nutritional deficiencies, ESG’s minimally invasive nature reduces these risks substantially.</p><figure id="figure-i3w436xdzslwexuvd9"><img id="i3w436xdzslwexuvd9" src="https://cdn.durable.co/shutterstock/18autZTJAwQuj2hST5j6oldbfa4698r9G3T4oPVoOkkahH5kdl40gX4HUqIplbT7.jpeg" alt="Blonde female doctor and patient talking in hospital office. Health care and client service in medicine" title="Blonde female doctor and patient talking in hospital office. Health care and client service in medicine" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionX="undefined" data-positionY="undefined" data-fullWidth="false"/></figure><h3>Patient Selection and Suitability</h3><p>Identifying suitable candidates for ESG is crucial for achieving optimal outcomes. Recent guidelines and studies emphasize the importance of patient selection criteria:</p><p><strong>1. Body Mass Index (BMI): </strong>ESG is typically recommended for patients with a BMI of 30-40 who have not had success with diet and exercise alone. It is also considered for patients with a BMI over 40 who are seeking a less invasive option than traditional surgery.</p><p><strong>2. Comorbidities:</strong> Patients with obesity-related comorbidities such as type 2 diabetes, hypertension, and obstructive sleep apnea may benefit significantly from ESG. The procedure can help improve these conditions, contributing to overall health improvement.</p><p><strong>3. Previous Weight Loss Efforts:</strong> ESG is often recommended for patients who have tried and failed to achieve significant weight loss through conventional methods. It is also considered for those who are not candidates for or do not want traditional bariatric surgery.</p><h3>Future Prospects and Ongoing Research</h3><p>The future of ESG looks promising, with ongoing research exploring ways to enhance its effectiveness and broaden its application. Some key areas of focus include:</p><p><strong>1. Technological Advancements: </strong>Innovations in endoscopic devices and techniques are continually improving the safety and efficacy of ESG. New suturing devices and methods are being developed to create more durable and effective gastric sleeves.<br><strong>2. Combination Therapies: </strong>Researchers are investigating the potential of combining ESG with other weight loss treatments, such as pharmacotherapy and lifestyle interventions, to enhance outcomes. This multimodal approach could offer more comprehensive and sustained weight loss.<br><strong>3. Long-term Studies:</strong> Continued research on the long-term effects of ESG is essential. Studies tracking patients over five to ten years will provide valuable data on weight maintenance, metabolic improvements, and quality of life.<br><strong>4. Expanding Indications:</strong> There is interest in exploring the use of ESG for patients with lower BMIs and those with metabolic disorders. This could expand the procedure’s applicability and benefit a broader range of patients.</p><h3>Conclusion</h3><p>Endoscopic gastroplasty represents a significant advancement in the field of weight loss interventions. Recent studies underscore its effectiveness, safety, and potential as a minimally invasive alternative to traditional bariatric surgeries. As research continues and technology advances, ESG is poised to play a crucial role in the management of obesity and its related conditions. For patients seeking a less invasive, yet effective weight loss solution, endoscopic gastroplasty offers a promising option with encouraging long-term outcomes.</p>

Understanding Endoscopic Gastroplasty: A Review of Recent Studies

<p>Endoscopic methods for weight loss are becoming increasingly popular as a minimally invasive alternative to traditional weight loss surgeries. These procedures involve the use of an endoscope, a flexible tube with a light and camera, to perform various weight loss interventions without the need for large incisions.</p><h3>The Endoscopic Sleeve Gastroplasty (ESG)</h3><p>One of the most well-known endoscopic weight loss procedures is the Endoscopic Sleeve Gastroplasty (ESG). This non-surgical procedure reduces the size of the stomach using sutures and is designed to help patients feel full sooner, resulting in reduced food intake and subsequent weight loss.</p><figure id="figure-q56hkmhwnnlqsp76b7"><img id="q56hkmhwnnlqsp76b7" src="https://cdn.durable.co/shutterstock/9hOBvsrSTukSz2RAcCe6Cz7dOmfQrZMIcFapw5xdilncIcqwrhIpmOVmGgg4ngoY.jpeg" alt="Endoscopy at the hospital. Doctor holding endoscope before gastroscopy. Medical examination" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionX="null" data-positionY="null"/></figure><h3>Gastric Balloon Placement</h3><p>Another common endoscopic method for weight loss is the placement of a gastric balloon. This involves inserting a deflated balloon into the stomach and then inflating it to reduce the amount of space available for food, leading to a feeling of fullness with smaller portions.</p><h3>Endoscopic Intragastric Balloon</h3><p>The Endoscopic Intragastric Balloon is a type of gastric balloon that is inserted and removed endoscopically. It is a temporary weight loss option that can help patients achieve significant weight loss by reducing the amount of food the stomach can hold.</p><figure id="figure-1eu7q9x78hlqsp77g7"><img id="1eu7q9x78hlqsp77g7" src="https://cdn.durable.co/blocks/22wj7mHletJdgbKIXByP5Si7aUpNgVG5chGXemna8D9V8EhVVJBtEIovkM5wI7jr.jpg" alt="intragastric balloon" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9; object-position: center center;" data-corners="default" data-aspect="16:9" data-caption="" data-positionx="null" data-positiony="null" data-mce-src="https://cdn.durable.co/blocks/22wj7mHletJdgbKIXByP5Si7aUpNgVG5chGXemna8D9V8EhVVJBtEIovkM5wI7jr.jpg" data-mce-style="aspect-ratio: 16/9; object-position: center center;"></figure><h3>Benefits of Endoscopic Weight Loss Methods</h3><p>Endoscopic weight loss procedures offer several benefits, including minimal scarring, shorter recovery times, and reduced risk of complications compared to traditional weight loss surgeries. These methods also provide an option for patients who may not be suitable candidates for more invasive procedures.</p><h3>Potential Risks and Considerations</h3><p>While endoscopic weight loss methods are generally considered safe, there are potential risks to be aware of, such as infection, balloon deflation, or migration. It's important for individuals considering these procedures to discuss the potential risks and benefits with a qualified healthcare professional.</p><h3>Post-Procedure Lifestyle Changes</h3><p>Following an endoscopic weight loss procedure, patients are typically advised to make significant lifestyle changes, including adopting a healthy diet and increasing physical activity to maximize the results of the intervention.</p><figure id="figure-zeidjrx9fllqsp78yc"><img id="zeidjrx9fllqsp78yc" src="https://images.unsplash.com/photo-1607962837359-5e7e89f86776?crop=entropy&amp;cs=tinysrgb&amp;fit=max&amp;fm=jpg&amp;ixid=M3wyNjI5NjF8MHwxfHNlYXJjaHwyfHxoZWFsdGh5JTIwbGlmZXN0eWxlfGVufDB8fHx8MTcwMzk3OTE2OHww&amp;ixlib=rb-4.0.3&amp;q=80&amp;w=1080" alt="healthy lifestyle" class="object-cover bg-gray-100 rounded-2xl md:rounded-3xl lg:rounded-4xl" style="aspect-ratio: 16/9;" data-mce-src="https://images.unsplash.com/photo-1607962837359-5e7e89f86776?crop=entropy&amp;cs=tinysrgb&amp;fit=max&amp;fm=jpg&amp;ixid=M3wyNjI5NjF8MHwxfHNlYXJjaHwyfHxoZWFsdGh5JTIwbGlmZXN0eWxlfGVufDB8fHx8MTcwMzk3OTE2OHww&amp;ixlib=rb-4.0.3&amp;q=80&amp;w=1080" data-mce-style="aspect-ratio: 16/9;"></figure><h3>Effectiveness and Long-Term Outcomes</h3><p>Studies have shown that endoscopic weight loss methods can be effective in helping patients achieve significant weight loss and improvements in obesity-related health conditions. However, long-term outcomes may vary, and ongoing support and monitoring are essential for sustained success.</p><h3>Consultation and Evaluation</h3><p>Prior to undergoing any endoscopic weight loss procedure, individuals should undergo a thorough evaluation and consultation with a healthcare provider to determine the most suitable treatment option based on their unique medical history and weight loss goals.</p><p>Overall, endoscopic methods for weight loss offer a less invasive alternative for individuals seeking to achieve significant weight loss and improve their overall health. With advancements in technology and ongoing research, these procedures continue to evolve, providing new options for individuals struggling with obesity.</p>

Apollo Endosleeve

Blog

Big News! IFSO Endorsed ESG!

ESG is a Cost Effective and Sustainable Solution!

Understanding Endoscopic Gastroplasty: A Review of Recent...

Endoscopic methods for weight loss.